|
Market Closed -
NSE India S.E.
09:05:07 11/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 5,087.50 INR | -0.98% |
|
-2.03% | -7.61% |
| 08/09 | Alkem Laboratories Limited Launches Renocia Exo, India?s First Patented Ginsenoside Exosome-Based Hair Growth Serum | CI |
| 14/08 | Alkem Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.43B | |||||
| 1,001B | |||||
| 642B | - | - | - | ||
| 451B | |||||
| 340B | |||||
| 263B |
Select your edition
All financial news and data tailored to specific country editions
